Tejpar S - Search Results

1

Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer.

Van Cutsem E, Lenz HJ, Köhne CH, Heinemann V, Tejpar S, Melezínek I, Beier F, Stroh C, Rougier P, van Krieken JH, Ciardiello F. Van Cutsem E, et al. Among authors: tejpar s. J Clin Oncol. 2015 Mar 1;33(7):692-700. doi: 10.1200/JCO.2014.59.4812. Epub 2015 Jan 20. J Clin Oncol. 2015. PMID: 25605843 Free article. Clinical Trial.

2

Screening for colorectal cancer.

Van Cutsem E, Tejpar S, Rutgeerts P, Janssens J. Van Cutsem E, et al. Among authors: tejpar s. Acta Gastroenterol Belg. 1995 Sep-Dec;58(5-6):397-404. Acta Gastroenterol Belg. 1995. PMID: 8775996

3

The molecular basis of colorectal cancer.

Tejpar S, Cassiman JJ, Van Cutsem E. Tejpar S, et al. Acta Gastroenterol Belg. 2001 Jul-Sep;64(3):249-54. Acta Gastroenterol Belg. 2001. PMID: 11680042 Review.

4

Molecular and genetic defects in colorectal tumorigenesis.

Tejpar S, Van Cutsem E. Tejpar S, et al. Best Pract Res Clin Gastroenterol. 2002 Apr;16(2):171-85. doi: 10.1053/bega.2001.0279. Best Pract Res Clin Gastroenterol. 2002. PMID: 11969232 Review.

5

Pathogenic mutations and rare variants of the APC gene identified in 75 Belgian patients with familial adenomatous polyposis by fluorescent enzymatic mutation detection (EMD).

Michils G, Tejpar S, Fryns JP, Legius E, Van Cutsem E, Cassiman JJ, Matthijs G. Michils G, et al. Among authors: tejpar s. Eur J Hum Genet. 2002 Sep;10(9):505-10. doi: 10.1038/sj.ejhg.5200825. Eur J Hum Genet. 2002. PMID: 12173026

6

Molecular defects in colorectal tumorigenesis.

Tejpar S, van Cutsem E. Tejpar S, et al. Drugs Today (Barc). 2003;39 Suppl C:111-8. Drugs Today (Barc). 2003. PMID: 14988749 Review.

7

Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposis (FAP): a Belgian study.

Michils G, Tejpar S, Thoelen R, van Cutsem E, Vermeesch JR, Fryns JP, Legius E, Matthijs G. Michils G, et al. Among authors: tejpar s. Hum Mutat. 2005 Feb;25(2):125-34. doi: 10.1002/humu.20122. Hum Mutat. 2005. PMID: 15643602

8

Oral capecitabine: bridging the Atlantic divide in colon cancer treatment.

Van Cutsem E, Verslype C, Tejpar S. Van Cutsem E, et al. Among authors: tejpar s. Semin Oncol. 2005 Feb;32(1):43-51. doi: 10.1053/j.seminoncol.2004.09.028. Semin Oncol. 2005. PMID: 15726505 Review.

9

Germline mutations of the hMLH1 and hMSH2 mismatch repair genes in Belgian hereditary nonpolyposis colon cancer (HNPCC) patients.

Spaepen M, Vankeirsbilck B, Van Opstal S, Tejpar S, Van Cutsem E, Geboes K, Legius E, Matthijs G. Spaepen M, et al. Among authors: tejpar s. Fam Cancer. 2006;5(2):179-89. doi: 10.1007/s10689-005-5958-6. Fam Cancer. 2006. PMID: 16736289

10

Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study.

Tejpar S, Piessevaux H, Claes K, Piront P, Hoenderop JG, Verslype C, Van Cutsem E. Tejpar S, et al. Lancet Oncol. 2007 May;8(5):387-94. doi: 10.1016/S1470-2045(07)70108-0. Lancet Oncol. 2007. PMID: 17466895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

255 results

Search Page

Filters